Journal Article

Down-Regulation by Resveratrol of Basic Fibroblast Growth Factor-Stimulated Osteoprotegerin Synthesis through Suppression of Akt in Osteoblasts

Otsuka, Takanobu, Kozawa, Osamu, Yamamoto, Naohiro, Matsushima-Nishiwaki, Rie, Nakakami, Akira, Kuroyanagi, Gen, Mizutani, Jun, Tokuda, Haruhiko

2014

Overview

It is firmly established that resveratrol, a natural food compound abundantly found in grape skins and red wine, has beneficial properties for human health. In the present study, we investigated the effect of basic fibroblast growth factor (FGF-2) on osteoprotegerin (OPG) synthesis in osteoblast-like MC3T3-E1 cells and whether resveratrol affects the OPG synthesis. FGF-2 stimulated both the OPG release and the expression of OPG mRNA. Resveratrol significantly suppressed the FGF-2-stimulated OPG release and the mRNA levels of OPG. SRT1720, an activator of SIRT1, reduced the FGF-2-induced OPG release and the OPG mRNA expression. PD98059, an inhibitor of upstream kinase activating p44/p42 mitogen-activated protein (MAP) kinase, had little effect on the FGF-2-stimulated OPG release. On the other hand, SB203580, an inhibitor of p38 MAP kinase, SP600125, an inhibitor of stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and Akt inhibitor suppressed the OPG release induced by FGF-2. Resveratrol failed to affect the FGF-2-induced phosphorylation of p44/p42 MAP kinase, p38 MAP kinase or SAPK/JNK. The phosphorylation of Akt induced by FGF-2 was significantly suppressed by resveratrol or SRT1720. These findings strongly suggest that resveratrol down-regulates FGF-2-stimulated OPG synthesis through the suppression of the Akt pathway in osteoblasts and that the inhibitory effect of resveratrol is mediated at least in part by SIRT1 activation.

• Publisher: MDPI AG,MDPI
• Subject: 3T3 Cells / Animals / Anthracenes - pharmacology / Anti-Inflammatory Agents, Non-Steroidal - pharmacology / Cellular biology / Down-Regulation - drug effects / Fibroblast Growth Factor 2 - genetics / Fibroblast Growth Factor 2 - metabolism / Fibroblast Growth Factor 2 - pharmacology / Flavonoids - pharmacology / Gene expression / Heterocyclic Compounds, 4 or More Rings - pharmacology / Imidazoles - pharmacology / JNK Mitogen-Activated Protein Kinases - antagonists & inhibitors / JNK Mitogen-Activated Protein Kinases - metabolism / Mice / Mitogen-Activated Protein Kinase 1 - antagonists & inhibitors / Mitogen-Activated Protein Kinase 1 - metabolism / Mitogen-Activated Protein Kinase 3 - antagonists & inhibitors / Mitogen-Activated Protein Kinase 3 - metabolism / Osteoblasts - cytology / Osteoblasts - drug effects / Osteoblasts - metabolism / Osteoprotegerin - genetics / Osteoprotegerin - metabolism / p38 Mitogen-Activated Protein Kinases - antagonists & inhibitors / p38 Mitogen-Activated Protein Kinases - metabolism / Phosphorylation - drug effects / Polyphenols / Protein synthesis / Proto-Oncogene Proteins c-akt - antagonists & inhibitors / Proto-Oncogene Proteins c-akt - metabolism / Pyridines - pharmacology / Recombinant Proteins - biosynthesis / Recombinant Proteins - genetics / Recombinant Proteins - pharmacology / Stilbenes - pharmacology